InsidersTradesSigma
Total declarations
Companies
▲ Purchases (3 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
3
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-9.9%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the full record of transactions filed by Cohen Jon R, Président Exécutif. Insider active across 2 companies, notably Opko Health, INC.. In total, 13 reports have been recorded. Breakdown: 3 buys · 0 sell. Total volume traded: €520k. History available since 10 May 2021. The latest transaction was filed on 7 March 2025 (Retenue fiscale). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations13 total
99,720 sharesCommon StockSEC:0001193125-26-273178:0
28,165 shares@ US$2.868.6% of flowCommon StockSEC:0000950170-25-037530:0
358,681 shares0Common StockSEC:0000950170-25-032975:0
75,000 shares@ US$2.8623.8% of flowCommon StockSEC:0000950170-25-031283:0
Ideal exit: 25 Nov 2025 (T+270)
75,902 shares@ US$3.4228.3% of flowCommon StockSEC:0000950170-24-135071:0
39,884 shares@ US$2.008.4% of flowCommon StockSEC:0001140361-24-041051:0
10,053 shares@ US$2.132.3% of flowCommon StockSEC:0001140361-24-031466:0
37,453 shares@ US$2.6210.4% of flowCommon StockSEC:0001140361-24-029759:0
29,321 shares@ US$2.999.3% of flowCommon StockSEC:0001140361-24-012289:0
1,250,000 shares0Common StockSEC:0001140361-24-011560:0
78,765 shares@ US$0.959.0% of flowCommon StockSEC:0001140361-22-035066:0
50,000 shares@ US$3.8150.0% of flowCommon StockSEC:0001209191-21-036771
Ideal exit: 4 Feb 2022 (T+270)
50,000 shares@ US$3.810.016% mcap50.0% of flowCommon StockSEC:0001209191-21-036771:0
Ideal exit: 4 Feb 2022 (T+270)
13 of 13 declarations
About Cohen Jon R
Jon R. Cohen is the Executive Chairman at OPKO Health, Inc. and Executive Chairman of BRLI. He plays a key role in corporate governance and strategy for both organizations. His experience in the healthcare and biotechnology sectors is essential for guiding OPKO and BRLI towards innovation.
